SCHEMBL31280720

SCHEMBL31280720

COc1cc(F)ccc1C(O)C(C)(F)F

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 7/20 0.40
NR3C1 P04150 16/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31205405 0.88 SCN9A (0.36) NR3C2NR3C1KDM4E
SCHEMBL23293136 0.80 KDM4E (0.39) KDM4E
SCHEMBL31280849 0.80 KDM4E (0.38) NR3C2NR3C1KDM4E
SCHEMBL12563119 0.79 MGAM (0.42) KDM4E
SCHEMBL12993119 0.79 MGAM (0.42) KDM4E
SCHEMBL31280390 0.78 SCN9A (0.34)
SCHEMBL25482195 0.77 KDM4E (0.41) NR3C2KDM4E
SCHEMBL19757661 0.76 PDE2A (0.45) KDM4E
SCHEMBL30910945 0.76 KDM4E (0.43) NR3C2NR3C1KDM4E
SCHEMBL31280542 0.76 PDE2A (0.45) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727941-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF Lynk Pharmaceuticals Co. Ltd. (CN) 2026-04-22 EP disclosed
WO-2024255885-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-12-19 WO disclosed